- Home
- SIGA vs BGY Comparison
SIGA vs BGY Comparison
Compare SIGA & BGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- BGY
- Stock Information
- Founded
- SIGA 1995
- BGY 2007
- Country
- SIGA United States
- BGY United States
- Employees
- SIGA N/A
- BGY N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- BGY Trusts Except Educational Religious and Charitable
- Sector
- SIGA Health Care
- BGY Finance
- Exchange
- SIGA Nasdaq
- BGY Nasdaq
- Market Cap
- SIGA 443.4M
- BGY 529.9M
- IPO Year
- SIGA 1997
- BGY N/A
- Fundamental
- Price
- SIGA $6.32
- BGY $5.49
- Analyst Decision
- SIGA
- BGY
- Analyst Count
- SIGA 0
- BGY 0
- Target Price
- SIGA N/A
- BGY N/A
- AVG Volume (30 Days)
- SIGA 422.2K
- BGY 208.4K
- Earning Date
- SIGA 03-11-2025
- BGY 01-01-0001
- Dividend Yield
- SIGA 9.53%
- BGY 7.41%
- EPS Growth
- SIGA N/A
- BGY N/A
- EPS
- SIGA 1.20
- BGY N/A
- Revenue
- SIGA $173,731,386.00
- BGY N/A
- Revenue This Year
- SIGA $16.79
- BGY N/A
- Revenue Next Year
- SIGA $15.08
- BGY N/A
- P/E Ratio
- SIGA $5.30
- BGY N/A
- Revenue Growth
- SIGA 399.31
- BGY N/A
- 52 Week Low
- SIGA $4.26
- BGY $4.68
- 52 Week High
- SIGA $12.83
- BGY $5.66
- Technical
- Relative Strength Index (RSI)
- SIGA 51.04
- BGY 57.16
- Support Level
- SIGA $6.16
- BGY $5.20
- Resistance Level
- SIGA $6.58
- BGY $5.45
- Average True Range (ATR)
- SIGA 0.26
- BGY 0.06
- MACD
- SIGA 0.04
- BGY 0.02
- Stochastic Oscillator
- SIGA 68.67
- BGY 98.28
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About BGY Blackrock Enhanced International Dividend Trust
Blackrock Enhanced International Dividend Trust has an investment objective to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its objectives by investing in equity securities of companies engaged in the energy and natural resources business and equity derivatives with exposure to the energy and natural resources industry.